Presentation is loading. Please wait.

Presentation is loading. Please wait.

Fig. 3. Comparative RFS in response to combination of RFA and TACE vs

Published bySilas Carr Modified over 6 years ago

Similar presentations

Presentation on theme: "Fig. 3. Comparative RFS in response to combination of RFA and TACE vs"— Presentation transcript:

1 Fig. 3. Comparative RFS in response to combination of RFA and TACE vs
Fig. 3. Comparative RFS in response to combination of RFA and TACE vs. RFA alone for HCC.Meta-analysis demonstrated that RFA plus TACE therapy was associated with significantly higher RFS than that RFA monotherapy. CI = confidence interval, HCC = hepatocellular carcinoma, RFA = radiofrequency ablation, RFS = recurrence-free survival, SE = standard error, TACE = transcatheter arterial chemoembolizaton Fig. 3. Comparative RFS in response to combination of RFA and TACE vs. RFA alone for HCC.Meta-analysis demonstrated that RFA plus TACE therapy was associated with significantly higher RFS than that RFA monotherapy. CI = confidence interval, HCC = hepatocellular carcinoma, RFA = radiofrequency ablation, RFS = recurrence-free survival, SE = standard error, TACE. . . Korean J Radiol Jan-Feb;17(1):

Download ppt "Fig. 3. Comparative RFS in response to combination of RFA and TACE vs"

Similar presentations

Staging Strategy and Treatment for Patients With HCC

Staging Strategy and Treatment for Patients With HCC
High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.

High-Intensity Focused Ultrasound for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Queen Mary Hospital 19/10/2013.
Current Evidence in Ablative Therapy for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Dr Chu Ka Wan Queen Mary Hospital.

Current Evidence in Ablative Therapy for Hepatocellular Carcinoma Joint Hospital Surgical Grand Round Dr Chu Ka Wan Queen Mary Hospital.
Joint Hospital Surgical Grand Round 16th Jan 2010 Dr James Fung Department of Surgery United Christian Hospital.

Joint Hospital Surgical Grand Round 16th Jan 2010 Dr James Fung Department of Surgery United Christian Hospital.
Liver Cancer Management with Y90 Glass Microspheres – TheraSphere Experience and Challenges in HCC Thomas Lauenstein, MD Department of Diagnostic and.

Liver Cancer Management with Y90 Glass Microspheres – TheraSphere Experience and Challenges in HCC Thomas Lauenstein, MD Department of Diagnostic and.
57445 HCC were registered 31743 HCC with complete data 10114 underwent surgical resection 9577 underwent local ablation therapies 9283 underwent TACE 1150.

57445 HCC were registered HCC with complete data underwent surgical resection 9577 underwent local ablation therapies 9283 underwent TACE 1150.
In the name of Alla. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.

In the name of Alla. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Chapter 14: Inference about the Model. Confidence Intervals for the Regression Slope (p. 788) If we repeated our sampling and computed another model,

Chapter 14: Inference about the Model. Confidence Intervals for the Regression Slope (p. 788) If we repeated our sampling and computed another model,
Intermediate stage HCC treatment options: Y 90 -labelled microspheres.

Intermediate stage HCC treatment options: Y 90 -labelled microspheres.
Fotlos Laspas'. Evangelia Sotiropoitlou'. Sophia Myhna^. Anita Manataki', Paraskevi TsagouW. Iris Tsangaridou', Loukas Thanos'

Fotlos Laspas'. Evangelia Sotiropoitlou'. Sophia Myhna^. Anita Manataki', Paraskevi TsagouW. Iris Tsangaridou', Loukas Thanos'
K Nouso, K Miyahara, D Uchida, K Kuwaki, N Izumi, M Omata, T Ichida, M Kudo, Y Ku, N Kokudo, M Sakamoto, O Nakashima, T Takayama, O Matsui, Y Matsuyama,

K Nouso, K Miyahara, D Uchida, K Kuwaki, N Izumi, M Omata, T Ichida, M Kudo, Y Ku, N Kokudo, M Sakamoto, O Nakashima, T Takayama, O Matsui, Y Matsuyama,
Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),

Fig. 3. Gadoxetic acid-enhanced MRI in 69-year-old man with chronic hepatitis C.On arterial phase (A), 1.2 cm enhancing nodule is seen in S8 (arrows),
Volume 61, Issue 1, Pages (July 2014)

Volume 61, Issue 1, Pages (July 2014)
Fig year-old woman with invasive lobular breast cancer. A

Fig year-old woman with invasive lobular breast cancer. A
Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study  Kit-fai.

Long-term outcomes of microwave versus radiofrequency ablation for hepatocellular carcinoma by surgical approach: A retrospective comparative study  Kit-fai.
From: A Review of Therapeutic Ablation Modalities

From: A Review of Therapeutic Ablation Modalities
Volume 18, Issue 9, Pages (September 2016)

Volume 18, Issue 9, Pages (September 2016)
Date of download: 10/29/2017 Copyright © ASME. All rights reserved.

Date of download: 10/29/2017 Copyright © ASME. All rights reserved.
Masatoshi Kudo  Clinical Gastroenterology and Hepatology 

Masatoshi Kudo  Clinical Gastroenterology and Hepatology 
Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and.

Fig. 4. First-line treatment according to 2014 KLCSG-NCC Korea Practice Guidelines for patients with HCC, Child-Pugh class A, no portal hypertension, and.

Similar presentations

Ads by Google